Clinical trial
GM-CSF for Maintenance of Prostate Cancer for Patients Responding to Taxotere
NCT00274287 · Oncology Specialists, S.C., Other · Completed
Key facts
| NCT number | NCT00274287 |
|---|---|
| Title | GM-CSF for Maintenance of Prostate Cancer for Patients Responding to Taxotere |
| Official title | A Phase II Pilot Study Investigating the Efficacy and Activity of Single Agent GM-CSF (Leukine) Maintenance Approach in Androgen-independent Prostate Cancer (AIPC) Patients Responding to Taxotere Chemotherapy |
| Lead sponsor | Oncology Specialists, S.C., Other |
| Collaborators | Genzyme, a Sanofi Company Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Prostate Cancer |
| Intervention type | Drug |
| Interventions | GM CSF |
| Enrollment | 15 |
| Start date | Jan 1, 2006 |
| Primary completion | Dec 1, 2010 |
| Completion | Dec 1, 2010 |
| First posted | Jan 10, 2006 |
| Last update posted | Mar 28, 2019 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: